Literature DB >> 25613433

A very simple formula to compute pCO2 in hemodialysis patients.

Marco Marano1, Anna D'Amato, Stefano Marano.   

Abstract

PURPOSE: To identify mixed acid-base disorders, clinicians must estimate the value of partial pressure of carbonic dioxide (pCO2), complying with the reduced plasma bicarbonate concentration (HCO3). What is the most appropriate equation relating the two quantities in chronic hemodialysis patients remains unknown. Chronic hemodialysis patients remains unknown, which motivates our study.
METHODS: Among a large database of blood gas analysis from chronic hemodialysis patients, we selected 291 blood samples showing HCO3 < 24 mmol/L and, among these, we further selected a subset of samples claimed for pure metabolic acidosis. A linear approximation based upon the least-square criterion was adopted to derive the best-fit equation. The differences between this and other commonly used formulas were computed in terms of root mean square (RMS) errors.
RESULTS: In chronic hemodialysis patients, the reduction in pCO2 due to metabolic acidosis is better predicted multiplying by 1.2 the reduction in HCO3, or by using the expression pCO2 = HCO3 + 15; the two approaches lead to almost the same results. In contrast, the equation pCO2 = 1.5 × HCO3 + 8, known as Winters' formula, exhibits larger errors.
CONCLUSIONS: The easy-to-use expression pCO2 = HCO3 + 15 seems suitable for the daily clinical practice in hemodialysis patients. However, if HCO3 value is lower than 12 mmol/L, a threshold at which different formulas return almost the same value, also Winters' formula, derived in the 60's from patients with low values of HCO3, could be used.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25613433     DOI: 10.1007/s11255-015-0913-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

Review 1.  What unique acid-base considerations exist in dialysis patients?

Authors:  Man S Oh; Jaime Uribarri; Jordan Weinstein; Martin Schreiber; Kamel S Kamel; Jeffrey A Kraut; Nicolaos E Madias; Melvin E Laski
Journal:  Semin Dial       Date:  2004 Sep-Oct       Impact factor: 3.455

2.  Secondary responses to altered acid-base status: the rules of engagement.

Authors:  Horacio J Adrogué; Nicolaos E Madias
Journal:  J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 10.121

3.  [On the use of Winters' formula in chronic metabolic acidosis].

Authors:  Marco Marano
Journal:  Rev Psiquiatr Salud Ment       Date:  2014-11-28       Impact factor: 3.318

Review 4.  Physiological approach to assessment of acid-base disturbances.

Authors:  Kenrick Berend; Aiko P J de Vries; Rijk O B Gans
Journal:  N Engl J Med       Date:  2014-10-09       Impact factor: 91.245

5.  Arterial PCO2 in chronic metabolic acidosis.

Authors:  D A Bushinsky; F L Coe; C Katzenberg; J P Szidon; J H Parks
Journal:  Kidney Int       Date:  1982-09       Impact factor: 10.612

6.  Quantitative displacement of acid-base equilibrium in metabolic acidosis.

Authors:  M S Albert; R B Dell; R W Winters
Journal:  Ann Intern Med       Date:  1967-02       Impact factor: 25.391

7.  Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality.

Authors:  Tania Vashistha; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Klara Torlén; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-26       Impact factor: 8.237

  7 in total
  3 in total

1.  Respiratory alkalosis: the first drop of lung water?

Authors:  Marco Marano; Anna D'Amato; Stefano Marano
Journal:  Int Urol Nephrol       Date:  2015-02-13       Impact factor: 2.370

Review 2.  Carbon dioxide: Global warning for nephrologists.

Authors:  Marco Marano; Anna D'Amato; Alessandra Cantone
Journal:  World J Nephrol       Date:  2016-09-06

3.  Metabolic and volume status evaluation of hemodialysis patients with and without residual renal function in the long interdialytic interval.

Authors:  Lenina Ludimila Sampaio de Almeida; Luís Henrique Bezerra Cavalanti Sette; Fernando Luiz Affonso Fonseca; Leila Silveira Vieira da Silva Bezerra; Francisco Hélio Oliveira Júnior; Ronaldo Roberto Bérgamo
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.